Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.

J. Rangaswamy (Melbourne, Australia), S. Avery (Melbourne, Australia), B. Borg (Melbourne, Australia), C. Martin (Melbourne, Australia), E. Dabscheck (Melbourne, Australia)

Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Session: The importance of the pulmonary function test in different clinical settings
Session type: Poster Discussion
Number: 5298
Disease area: Airway diseases

Congress or journal article abstractE-posterSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Rangaswamy (Melbourne, Australia), S. Avery (Melbourne, Australia), B. Borg (Melbourne, Australia), C. Martin (Melbourne, Australia), E. Dabscheck (Melbourne, Australia). Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.. 5298

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016

Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004



Incidence and risk factors for bronchiolitis obliterans syndrome stage 0p after lung transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018


Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 177s
Year: 2004

Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation
Source: Eur Respir J 2014; 43: 221-232
Year: 2004



Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation
Source: Eur Respir J 2011; 38: 470-472
Year: 2011


Long term follow-up of patients with Bronchiolitis obliterans Syndrome after hematopoietic stem cell transplantation
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019

Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


Late pulmonary complications after haematopoietic stem cell transplantation (HSCT) in children: incidence and risk factors
Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects
Year: 2008



Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation?
Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible?
Year: 2006


Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011

Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant
Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017
Year: 2018



Bronchiolitis obliterans following haematopoietic stem cell transplantation
Source: Eur Respir J 2007; 29: 1007-1019
Year: 2007



Bronchiectasis as prognostic factor in bronchiolitis obliterans syndrome after lung transplantation
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018



Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
Source: Eur Respir J 2005; 25: 402-405
Year: 2005


Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1
Year: 2004

Bronchiolitis obliterans syndrome (BOS) after bone marrow transplantation (BMT) in childhood
Source: Eur Respir J 2003; 22: Suppl. 45, 144s
Year: 2003

Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Source: Eur Respir J 2005; 25: 221-224
Year: 2005



Infection and bronchiolitis obliterans syndrome in lung transplant recipients
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44
Year: 2004

Clinical course of patients with bronchiolitis obliterans after hematopoietic stem cell transplantation
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014